 0 Table of Contents |
  1 Home |
  2 HIQA Alignment |
  3 HIQA Traceability |
  4 Data Minimisation |
  5 Administration and Statements |
  6 Terminology |
  7 Open Issues |
  8 Simplifier Publishing |
  9 Changes |
  10 Downloads |
  11 Artifacts Summary |
   11.1 HIQA ePrescription and eDispensation Dataset (draft, Sept 2026) |
   11.2 IE MPD Allergy Statement at Prescribing |
   11.3 IE MPD AllergyIntolerance |
   11.4 IE MPD Body Height |
   11.5 IE MPD Body Weight |
   11.6 IE MPD Bundle (ePrescription) |
   11.7 IE MPD Bundle (ePrescription, cross-border) |
   11.8 IE MPD Location |
   11.9 IE MPD Medication (ePrescription/eDispensation) |
   11.10 IE MPD MedicationAdministration |
   11.11 IE MPD MedicationDispense |
   11.12 IE MPD MedicationDispense (eDispensation) |
   11.13 IE MPD MedicationRequest (ePrescription) |
   11.14 IE MPD MedicationStatement |
   11.15 IE MPD Organization |
   11.16 IE MPD Patient |
   11.17 IE MPD Patient (ePrescription/eDispensation) |
   11.18 IE MPD Practitioner |
   11.19 IE MPD PractitionerRole |
   11.20 IE MPD Provenance |
   11.21 IE MPD Provenance (ePrescription signature) |
   11.22 IE MPD RelatedPerson |
   11.23 IE MPD Vital Signs |
   11.24 IE MPD Country of Affiliation |
   11.25 IE MPD Dispense Receiver (Related Person) |
   11.26 IE MPD Do Not Extend |
   11.27 IE MPD Ethnicity |
   11.28 IE MPD Exempt Medication Item (Requires Clarification) |
   11.29 IE MPD Medicinal Product Is Interchangeable |
   11.30 IE MPD Mother's Former Surname |
   11.31 IE MPD Number of Instalments |
   11.32 IE MPD Patient Age at Prescribing |
   11.33 IE MPD Quantity Prescribed (Words and Figures) |
   11.34 IE MPD Age Units |
   11.35 IE MPD Allergy Intolerance Set |
   11.36 IE MPD Ethnicity |
   11.37 IE MPD Healthcare Provider Taxonomy |
   11.38 IE MPD Medication Codes |
   11.39 IE MPD Misuse of Drugs Schedule (placeholder) |
   11.40 IE MPD PCRS Scheme Type (placeholder) |
   11.41 IE MPD Provenance Participant Type |
   11.42 Ireland Counties |
   11.43 IE MPD County Codes |
   11.44 IE MPD Ethnicity Codes (CSO Data Standard for Ethnicity v1.0) |
   11.45 IE MPD Misuse of Drugs Schedule (placeholder) |
   11.46 IE MPD PCRS Scheme Type (placeholder) |
   11.47 IE MPD Provenance Participant Type |
   11.48 IE MPD Supply Legal Status (placeholder) |
   11.49 Dental Council of Ireland registration number |
   11.50 GMS Panel ID |
   11.51 Health Services Provider Identifier: individual (HSP-I) |
   11.52 Health Services Provider Identifier: organisation (HSP-O) |
   11.53 Individual Health Identifier (IHI) |
   11.54 Irish Medical Council registration number (MCRN) |
   11.55 National ePrescribing Service (NePS) prescription (group) identifier |
   11.56 Nursing and Midwifery Board of Ireland registration number |
   11.57 PCRS Drugs Payment Scheme (DPS) number |
   11.58 PCRS Health (Amendment) Act (HAA) card number |
   11.59 PCRS Long-Term Illness (LTI) scheme number |
   11.60 PCRS medical card (GMS) number |
   11.61 Personal Public Service Number (PPSN) |
   11.62 Pharmaceutical Society of Ireland registration number |
   11.63 PSI Retail Pharmacy Business registration number |
   11.64 HIQA scenarios – Allergy statement listing penicillin allergy (Niamh Keane) |
   11.65 HIQA scenarios – Allergy statement: no known allergies (Declan Walsh) |
   11.66 HIQA scenarios – Allergy statement: no known allergies (Oisín Brady) |
   11.67 HIQA scenarios – Allergy statement: no known allergies (Tomás Quinn) |
   11.68 HIQA scenarios – Allergy to penicillin (Niamh Keane) |
   11.69 HIQA scenarios – Amoxicillin 50 mg/mL oral suspension |
   11.70 HIQA scenarios – Amoxicillin 500 mg oral capsule |
   11.71 HIQA scenarios – Bridge Street Pharmacy (fictional) |
   11.72 HIQA scenarios – Declan Walsh (adult, fictional) |
   11.73 HIQA scenarios – Dr Clodagh Nolan (GP, fictional) |
   11.74 HIQA scenarios – Dr Clodagh Nolan at Riverside Family Practice |
   11.75 HIQA scenarios – Eoin Farrell (pharmacist, fictional) |
   11.76 HIQA scenarios – Niamh Keane (adult with asthma and penicillin allergy, fictional) |
   11.77 HIQA scenarios – Oisín Brady (5 years old, fictional) |
   11.78 HIQA scenarios – Oxycodone hydrochloride 10 mg prolonged-release tablet (Schedule 2) |
   11.79 HIQA scenarios – Riverside Family Practice (fictional) |
   11.80 HIQA scenarios – Salbutamol 100 micrograms/actuation pressurised inhaler |
   11.81 HIQA scenarios – Tomás Quinn (adult, fictional) |
   11.82 Medication – Atorvastatin 20mg Tablets |
   11.83 Medication – Metformin 500mg Tablets |
   11.84 Scenario 1 – Acute prescription: amoxicillin 500 mg for acute sinusitis |
   11.85 Scenario 1 – Dispense: amoxicillin 500 mg, completed |
   11.86 Scenario 1 – ePrescription Bundle: acute adult prescription |
   11.87 Scenario 2 – Body weight 19 kg (Oisín Brady) |
   11.88 Scenario 2 – ePrescription Bundle: paediatric prescription (under 12) |
   11.89 Scenario 2 – Paediatric prescription: amoxicillin suspension for acute otitis media |
   11.90 Scenario 3 – Dispense 1: part fill (1 of 2 inhalers) |
   11.91 Scenario 3 – Dispense 2: balance of the first supply |
   11.92 Scenario 3 – Dispense 3: first repeat |
   11.93 Scenario 3 – ePrescription Bundle: repeat prescription |
   11.94 Scenario 3 – Repeat prescription: salbutamol inhaler (5 repeats) |
   11.95 Scenario 4 – Controlled drug: oxycodone 10 mg prolonged-release (Schedule 2) |
   11.96 Scenario 4 – Dispense: instalment 1 of 2 (14 tablets) |
   11.97 Scenario 4 – ePrescription Bundle: controlled drug |
   11.98 Scenario 5 – ePrescription Bundle: prescription later declined |
   11.99 Scenario 5 – Non-dispensation: declined because of a recorded penicillin allergy |
   11.100 Scenario 5 – Prescription the pharmacist declines: amoxicillin for a patient with penicillin allergy |
   11.101 Scenario 6 – Cross-border ePrescription Bundle (IE → EU) with signature |
   11.102 Scenario 6 – Cross-border item 1: metformin 500 mg |
   11.103 Scenario 6 – Cross-border item 2: atorvastatin 20 mg |
   11.104 Scenario 6 – Prescriber signature over both items |
   11.105 Scenario 7 – Administration: salbutamol inhaler given in the GP practice |
   11.106 Scenario 8 – Administration not given: patient declined the dose |
   11.107 Scenario 9 – Medication statement: salbutamol inhaler when needed |